Approval · Notice of Compliance 484 · 2003
DOBUTAMINE: Notice of Compliance 484
Issued March 14, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 484
- Date
- March 14, 2003
- Company
- Ivax Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Inotropic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOBUTAMINE | 02229451 | Cancelled Post Market |
Medicinal ingredients
- DOBUTAMINE HCL 12.5 MG per ML